Industry concern over EU pharmacovigilance fees

24.02.2014

Pharma Times

Published 24 February 2014

The main trade associations that represent Europe's healthcare industry have called for "balanced and transparent funding" of the continent's pharmacovigilance system.

The European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Generic medicines Association (EGA), the European biotech industry (EuropaBio), the Association of the European Self-Medication Industry (AESGP) and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) have issued a joint statement about  their concerns for “the increasing financial burden of regulatory costs incurred since the adoption of the pharmacovigilance package in 2010″.The full article is available here.